Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Zealand Pharma may sell future obesity drug direct to patients, amid market shifts

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    22/09/2025 14:32
    LONDON, Sept 22 (Reuters) - Zealand Pharma ZELA.CO is considering a direct-to-patient sales model for its experimental weight-loss drug alongside traditional insurer channels, its CEO told Reuters in an interview on Monday, citing shifting dynamics in the booming obesity drug market.

 (Reporting by Maggie Fick; Editing by Jan Harvey)

 ((maggie.fick@thomsonreuters.com; +44 7890 916706;))

    Recent news on Zealand Pharma A/S

    See all news